Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes

10.1002/jgh3.12850

Saved in:
Bibliographic Details
Main Authors: Tan, Chee-Kiat, Luo, Xue-Shi, Ong, Benjamin Shao-Kiat, Lin, Liang, Ng, Kwong-Hoe
Other Authors: DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Format: Article
Language:English
Published: WILEY 2023
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/241706
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-241706
record_format dspace
spelling sg-nus-scholar.10635-2417062024-11-14T19:18:35Z Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes Tan, Chee-Kiat Luo, Xue-Shi Ong, Benjamin Shao-Kiat Lin, Liang Ng, Kwong-Hoe DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) Prof Chee Kiat Kenneth Tan Science & Technology Life Sciences & Biomedicine Gastroenterology & Hepatology chronic hepatitis C clinical practice patient outcomes real-world impact sofosbuvir-velpatasvir INFECTION 10.1002/jgh3.12850 JGH OPEN 7 1 48-54 2023-06-08T05:12:01Z 2023-06-08T05:12:01Z 2023-01 2023-06-06T03:53:49Z Article Tan, Chee-Kiat, Luo, Xue-Shi, Ong, Benjamin Shao-Kiat, Lin, Liang, Ng, Kwong-Hoe (2023-01). Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes. JGH OPEN 7 (1) : 48-54. ScholarBank@NUS Repository. https://doi.org/10.1002/jgh3.12850 2397-9070 2397-9070 https://scholarbank.nus.edu.sg/handle/10635/241706 en WILEY Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
chronic hepatitis C
clinical practice
patient outcomes
real-world impact
sofosbuvir-velpatasvir
INFECTION
spellingShingle Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
chronic hepatitis C
clinical practice
patient outcomes
real-world impact
sofosbuvir-velpatasvir
INFECTION
Tan, Chee-Kiat
Luo, Xue-Shi
Ong, Benjamin Shao-Kiat
Lin, Liang
Ng, Kwong-Hoe
Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
description 10.1002/jgh3.12850
author2 DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
author_facet DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Tan, Chee-Kiat
Luo, Xue-Shi
Ong, Benjamin Shao-Kiat
Lin, Liang
Ng, Kwong-Hoe
format Article
author Tan, Chee-Kiat
Luo, Xue-Shi
Ong, Benjamin Shao-Kiat
Lin, Liang
Ng, Kwong-Hoe
author_sort Tan, Chee-Kiat
title Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
title_short Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
title_full Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
title_fullStr Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
title_full_unstemmed Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
title_sort real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis c on clinical practice and patient outcomes
publisher WILEY
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/241706
_version_ 1821206057237610496